Skip to main content
Market intelligence
TWSTHealthcare

Twist Bioscience Corp insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 18, 2026Patrick John FinnPresident and COOSale78,355$117.64$9,217,604
Aug 12, 2026Katryn BlakeDirectorSale2,240$122.88$275,251
Aug 12, 2026Emily M. LeproustChief Executive OfficerSale19,952$125.08$2,495,508